Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

31.32
Delayed Data
As of Jul 29
 -0.45 / -1.42%
Today’s Change
29.24
Today|||52-Week Range
43.30
-7.86%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close31.77
Today’s open31.95
Day’s range31.07 - 31.95
Volume147,088
Average volume (3 months)373,219
Market cap$4.2B
Dividend yield2.08%
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+34.74%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)+21.57%
P/E ratio--
Price/Sales2.63
Price/Book3.38

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-1.26-2.43%
RAREUltragenyx Pharmaceu...-4.16-3.45%
IPXLImpax Laboratories I...-0.83-1.69%
ACADACADIA Pharmaceutica...-0.70-1.42%
Data as of 3:59pm ET, 07/29/2015

Financials

Last reporting dateJuly 30, 2015
EPS forecast (this quarter)$0.46
Annual revenue (last year)$4.4B
Annual profit (last year)$621.4M
Net profit margin14.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts